BioSpace News Archive

The importance of plasma is recognized during International Plasma Awareness Week, October 8-12. Grifols continues its commitment to plasma-derived medical treatments.

Famela Ramos announced today the Endorsement of Dr. Peter Farrell, the founder and Chairman of ResMed, the San Diego based global manufacturer of CPAP masks, machines and other products that diagnose, treat or help manage sleep-disordered breathing.

EDDA Technology, a global leading provider in advanced imaging-guided precision treatment solutions, announced today that the company has completed the installation of IQQA®- Liver MultiModality at Mayo Clinic in Jacksonville, Florida.

Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that it has commenced the U.S. pivotal trial that will study its self-expanding CENTERA transcatheter valve for severe, symptomatic aortic stenosis (AS) patients at intermediate risk of open-heart surgery.

- Diagnostics company sphingotec GmbH successfully closed €20 million growth equity financing round led by international specialist investors HBM Healthcare Investments, HBM BioCapital II LP (HBM) and Wellington Partners

First-of-Its-Kind Program Aims to Help Prevent Sonographer Injuries While Enhancing Patient Care and Reducing Costs

The Company will host a conference call and simultaneous webcast at 8:30 AM Eastern Time that day.

Acquisition adds the most advanced dermoscopy R&D Team to Canfield’s medical dermatology solutions, significantly expands European presence

Getinge is today announcing the launch of the Maquet PowerLED II Surgical Light. The Maquet PowerLED II Surgical Light brings best-in-class technology to surgical suites or Hybrid OR by improving working conditions for surgeons and staff.

Silver Oak Services Partners, LLC (“Silver Oak”), a leading lower middle market private equity firm focused exclusively on service businesses, announced it has led the recapitalization of Integrated Oncology Network (“ION” or the “Company”) in partnership with management and co-investors.